Complexity  ||| S:0 E:11 ||| JJ
modeling ||| S:11 E:19 ||| NN
:  ||| S:19 E:21 ||| :
identify  ||| S:21 E:30 ||| VB
instability  ||| S:30 E:42 ||| JJ
early  ||| S:42 E:48 ||| JJ
Biological  ||| S:48 E:59 ||| JJ
systems  ||| S:59 E:67 ||| NNS
are  ||| S:67 E:71 ||| VBP
innately  ||| S:71 E:80 ||| RB
complex ||| S:80 E:87 ||| JJ
,  ||| S:87 E:89 ||| ,
display  ||| S:89 E:97 ||| VBP
nonlinear  ||| S:97 E:107 ||| JJ
behavior ||| S:107 E:115 ||| NN
,  ||| S:115 E:117 ||| ,
and  ||| S:117 E:121 ||| CC
respond  ||| S:121 E:129 ||| VB
to  ||| S:129 E:132 ||| TO
both  ||| S:132 E:137 ||| DT
disease  ||| S:137 E:145 ||| NN
and  ||| S:145 E:149 ||| CC
its  ||| S:149 E:153 ||| PRP$
treatment  ||| S:153 E:163 ||| NN
in  ||| S:163 E:166 ||| IN
similar  ||| S:166 E:174 ||| JJ
complex  ||| S:174 E:182 ||| JJ
ways ||| S:182 E:186 ||| NNS
.  ||| S:186 E:188 ||| .
Complex  ||| S:188 E:196 ||| JJ
systems  ||| S:196 E:204 ||| NNS
display  ||| S:204 E:212 ||| VBP
self-organization  ||| S:212 E:230 ||| JJ
and  ||| S:230 E:234 ||| CC
predictive  ||| S:234 E:245 ||| JJ
behavior  ||| S:245 E:254 ||| NN
along  ||| S:254 E:260 ||| IN
a  ||| S:260 E:262 ||| DT
range  ||| S:262 E:268 ||| NN
of  ||| S:268 E:271 ||| IN
possible  ||| S:271 E:280 ||| JJ
states ||| S:280 E:286 ||| NNS
,  ||| S:286 E:288 ||| ,
often  ||| S:288 E:294 ||| RB
referred  ||| S:294 E:303 ||| VBN
to  ||| S:303 E:306 ||| TO
as  ||| S:306 E:309 ||| RB
chaotic  ||| S:309 E:317 ||| JJ
behavior ||| S:317 E:325 ||| NN
,  ||| S:325 E:327 ||| ,
and  ||| S:327 E:331 ||| CC
can  ||| S:331 E:335 ||| MD
be  ||| S:335 E:338 ||| VB
both  ||| S:338 E:343 ||| DT
characterized  ||| S:343 E:357 ||| NN
and  ||| S:357 E:361 ||| CC
quantified  ||| S:361 E:372 ||| VBN
in  ||| S:372 E:375 ||| IN
terms  ||| S:375 E:381 ||| NNS
of  ||| S:381 E:384 ||| IN
this  ||| S:384 E:389 ||| DT
chaotic  ||| S:389 E:397 ||| JJ
behavior ||| S:397 E:405 ||| NN
,  ||| S:405 E:407 ||| ,
which  ||| S:407 E:413 ||| WDT
defined  ||| S:413 E:421 ||| VBD
strange  ||| S:421 E:429 ||| JJ
attractors  ||| S:429 E:440 ||| NNS
( ||| S:440 E:441 ||| -LRB-
ρ ||| S:441 E:442 ||| LS
)  ||| S:442 E:444 ||| -RRB-
and  ||| S:444 E:448 ||| CC
variability ||| S:448 E:459 ||| NN
.  ||| S:459 E:461 ||| .
In  ||| S:461 E:464 ||| IN
this  ||| S:464 E:469 ||| DT
context ||| S:469 E:476 ||| NN
,  ||| S:476 E:478 ||| ,
disease  ||| S:478 E:486 ||| NN
can  ||| S:486 E:490 ||| MD
be  ||| S:490 E:493 ||| VB
characterized  ||| S:493 E:507 ||| VBN
as  ||| S:507 E:510 ||| IN
a  ||| S:510 E:512 ||| DT
difference  ||| S:512 E:523 ||| NN
in  ||| S:523 E:526 ||| IN
a  ||| S:526 E:528 ||| DT
disease  ||| S:528 E:536 ||| NN
state  ||| S:536 E:542 ||| NN
ρ  ||| S:542 E:544 ||| NNS
and  ||| S:544 E:548 ||| CC
a  ||| S:548 E:550 ||| DT
healthy  ||| S:550 E:558 ||| JJ
ρ ||| S:558 E:559 ||| NN
.  ||| S:559 E:561 ||| .
Furthermore ||| S:561 E:572 ||| RB
,  ||| S:572 E:574 ||| ,
effectiveness  ||| S:574 E:588 ||| NN
of  ||| S:588 E:591 ||| IN
treatment  ||| S:591 E:601 ||| NN
can  ||| S:601 E:605 ||| MD
be  ||| S:605 E:608 ||| VB
defined  ||| S:608 E:616 ||| VBN
as  ||| S:616 E:619 ||| IN
a  ||| S:619 E:621 ||| DT
minimization  ||| S:621 E:634 ||| JJ
problem  ||| S:634 E:642 ||| NN
to  ||| S:642 E:645 ||| TO
decrease  ||| S:645 E:654 ||| VB
the  ||| S:654 E:658 ||| DT
phase-state  ||| S:658 E:670 ||| JJ
difference  ||| S:670 E:681 ||| NN
between  ||| S:681 E:689 ||| IN
disease  ||| S:689 E:697 ||| NN
and  ||| S:697 E:701 ||| CC
health  ||| S:701 E:708 ||| NN
ρ  ||| S:708 E:710 ||| NN
values ||| S:710 E:716 ||| NNS
,  ||| S:716 E:718 ||| ,
such  ||| S:718 E:723 ||| JJ
that  ||| S:723 E:728 ||| IN
effective  ||| S:728 E:738 ||| JJ
treatment  ||| S:738 E:748 ||| NN
is  ||| S:748 E:751 ||| VBZ
defined  ||| S:751 E:759 ||| VBN
as  ||| S:759 E:762 ||| IN
the  ||| S:762 E:766 ||| DT
ability  ||| S:766 E:774 ||| NN
to  ||| S:774 E:777 ||| TO
restore  ||| S:777 E:785 ||| VB
the  ||| S:785 E:789 ||| DT
healthy  ||| S:789 E:797 ||| JJ
ρ ||| S:797 E:798 ||| NN
.  ||| S:798 E:800 ||| .
Importantly ||| S:800 E:811 ||| RB
,  ||| S:811 E:813 ||| ,
this  ||| S:813 E:818 ||| DT
approach  ||| S:818 E:827 ||| NN
will  ||| S:827 E:832 ||| MD
be  ||| S:832 E:835 ||| VB
effective  ||| S:835 E:845 ||| JJ
without  ||| S:845 E:853 ||| IN
anything  ||| S:853 E:862 ||| NN
being  ||| S:862 E:868 ||| VBG
known  ||| S:868 E:874 ||| VBN
about  ||| S:874 E:880 ||| IN
the  ||| S:880 E:884 ||| DT
physiologic  ||| S:884 E:896 ||| JJ
processes  ||| S:896 E:906 ||| NNS
that  ||| S:906 E:911 ||| IN
define  ||| S:911 E:918 ||| JJ
health  ||| S:918 E:925 ||| NN
or  ||| S:925 E:928 ||| CC
disease ||| S:928 E:935 ||| NN
.  ||| S:935 E:937 ||| .
The  ||| S:937 E:941 ||| DT
implication  ||| S:941 E:953 ||| NN
is  ||| S:953 E:956 ||| VBZ
that  ||| S:956 E:961 ||| IN
this  ||| S:961 E:966 ||| DT
approach  ||| S:966 E:975 ||| NN
is  ||| S:975 E:978 ||| VBZ
a  ||| S:978 E:980 ||| DT
powerful  ||| S:980 E:989 ||| JJ
tool  ||| S:989 E:994 ||| NN
to  ||| S:994 E:997 ||| TO
define  ||| S:997 E:1004 ||| VB
the  ||| S:1004 E:1008 ||| DT
determinants  ||| S:1008 E:1021 ||| NN
of  ||| S:1021 E:1024 ||| IN
instability  ||| S:1024 E:1036 ||| NN
as  ||| S:1036 E:1039 ||| IN
compared  ||| S:1039 E:1048 ||| VBN
with  ||| S:1048 E:1053 ||| IN
normal  ||| S:1053 E:1060 ||| JJ
variability ||| S:1060 E:1071 ||| NN
,  ||| S:1071 E:1073 ||| ,
to  ||| S:1073 E:1076 ||| TO
answer  ||| S:1076 E:1083 ||| VB
why  ||| S:1083 E:1087 ||| WRB
disease  ||| S:1087 E:1095 ||| NN
is  ||| S:1095 E:1098 ||| VBZ
not  ||| S:1098 E:1102 ||| RB
healthy ||| S:1102 E:1109 ||| JJ
,  ||| S:1109 E:1111 ||| ,
and  ||| S:1111 E:1115 ||| CC
to  ||| S:1115 E:1118 ||| TO
identify  ||| S:1118 E:1127 ||| VB
all  ||| S:1127 E:1131 ||| DT
potentially  ||| S:1131 E:1143 ||| RB
effective  ||| S:1143 E:1153 ||| JJ
treatment  ||| S:1153 E:1163 ||| NN
options  ||| S:1163 E:1171 ||| NNS
independent  ||| S:1171 E:1183 ||| JJ
of  ||| S:1183 E:1186 ||| IN
known  ||| S:1186 E:1192 ||| JJ
pharmacology  ||| S:1192 E:1205 ||| NN
and  ||| S:1205 E:1209 ||| CC
physiology ||| S:1209 E:1219 ||| NN
.  ||| S:1219 E:1221 ||| .
